BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 27158984)

  • 1. Diagnostic Performance of DNA Hypermethylation Markers in Peripheral Blood for the Detection of Colorectal Cancer: A Meta-Analysis and Systematic Review.
    Li B; Gan A; Chen X; Wang X; He W; Zhang X; Huang R; Zhou S; Song X; Xu A
    PLoS One; 2016; 11(5):e0155095. PubMed ID: 27158984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Assessment of septin9 DNA Methylation for Colorectal Cancer Using Blood Detection: A Meta-Analysis.
    Sun G; Meng J; Duan H; Zhang D; Tang Y
    Pathol Oncol Res; 2019 Oct; 25(4):1525-1534. PubMed ID: 30488278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review of blood diagnostic markers in colorectal cancer.
    Nikolaou S; Qiu S; Fiorentino F; Rasheed S; Tekkis P; Kontovounisios C
    Tech Coloproctol; 2018 Jul; 22(7):481-498. PubMed ID: 30022330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The performance of the SEPT9 gene methylation assay and a comparison with other CRC screening tests: A meta-analysis.
    Song L; Jia J; Peng X; Xiao W; Li Y
    Sci Rep; 2017 Jun; 7(1):3032. PubMed ID: 28596563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Value and Clinical Significance of Methylated SEPT9 for Colorectal Cancer: A Meta-Analysis.
    Hu J; Hu B; Gui YC; Tan ZB; Xu JW
    Med Sci Monit; 2019 Aug; 25():5813-5822. PubMed ID: 31378778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer.
    Warren JD; Xiong W; Bunker AM; Vaughn CP; Furtado LV; Roberts WL; Fang JC; Samowitz WS; Heichman KA
    BMC Med; 2011 Dec; 9():133. PubMed ID: 22168215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SEPT9: A Specific Circulating Biomarker for Colorectal Cancer.
    Song L; Li Y
    Adv Clin Chem; 2015; 72():171-204. PubMed ID: 26471083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of
    Sun J; Fei F; Zhang M; Li Y; Zhang X; Zhu S; Zhang S
    BMC Cancer; 2019 May; 19(1):450. PubMed ID: 31088406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma methylated septin 9: a colorectal cancer screening marker.
    Molnár B; Tóth K; Barták BK; Tulassay Z
    Expert Rev Mol Diagn; 2015 Feb; 15(2):171-84. PubMed ID: 25429690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating-tumour DNA methylation of HAND1 gene: a promising biomarker in early detection of colorectal cancer.
    Shavali M; Moradi A; Tahmaseb M; Mohammadian K; Ganji SM
    BMC Med Genomics; 2024 Apr; 17(1):117. PubMed ID: 38689296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of a second-generation methylated SEPT9 test in detecting colorectal neoplasm.
    Jin P; Kang Q; Wang X; Yang L; Yu Y; Li N; He YQ; Han X; Hang J; Zhang J; Song L; Han Y; Sheng JQ
    J Gastroenterol Hepatol; 2015 May; 30(5):830-3. PubMed ID: 25471329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From discovery to the clinic: the novel DNA methylation biomarker (m)SEPT9 for the detection of colorectal cancer in blood.
    Payne SR
    Epigenomics; 2010 Aug; 2(4):575-85. PubMed ID: 22121975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum methylation levels of TAC1. SEPT9 and EYA4 as diagnostic markers for early colorectal cancers: a pilot study.
    Liu Y; Tham CK; Ong SY; Ho KS; Lim JF; Chew MH; Lim CK; Zhao Y; Tang CL; Eu KW
    Biomarkers; 2013 Aug; 18(5):399-405. PubMed ID: 23862763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of a Novel Blood-Based Early Colorectal Cancer Screening Assay in Remaining Serum after the Blood Biochemical Test.
    Chen Y; Wang Z; Zhao G; Sun C; Ma Y; Zhang L; Zheng M; Li H
    Dis Markers; 2019; 2019():5232780. PubMed ID: 31089394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer screening with blood-based biomarkers: cost-effectiveness of methylated septin 9 DNA versus current strategies.
    Ladabaum U; Allen J; Wandell M; Ramsey S
    Cancer Epidemiol Biomarkers Prev; 2013 Sep; 22(9):1567-76. PubMed ID: 23796793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplex methylated DNA testing in plasma with high sensitivity and specificity for colorectal cancer screening.
    Zhao G; Li H; Yang Z; Wang Z; Xu M; Xiong S; Li S; Wu X; Liu X; Wang Z; Zhu Y; Ma Y; Fei S; Zheng M
    Cancer Med; 2019 Sep; 8(12):5619-5628. PubMed ID: 31407497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of the performance of the SEPT9 gene methylation assay in colorectal cancer screening, monitoring, diagnosis and prognosis.
    Song L; Yu H; Jia J; Li Y
    Cancer Biomark; 2017; 18(4):425-432. PubMed ID: 28128742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of stool DNA methylation in colorectal cancer diagnosis: A meta-analysis.
    Mojtabanezhad Shariatpanahi A; Yassi M; Nouraie M; Sahebkar A; Varshoee Tabrizi F; Kerachian MA
    PLoS One; 2018; 13(7):e0200735. PubMed ID: 30024936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of the colorectal cancer screening marker Sept9 is influenced by age, diabetes and arthritis: a nested case-control study.
    Ørntoft MB; Nielsen HJ; Ørntoft TF; Andersen CL;
    BMC Cancer; 2015 Oct; 15():819. PubMed ID: 26514170
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Laven-Law G; Kichenadasse G; Young GP; Symonds EL; Winter JM
    Biomarkers; 2024 Jun; 29(4):194-204. PubMed ID: 38644767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.